NCT03275103
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03275103
Title Dose-Escalation Study of BFCR4350A in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Genentech, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP | CAN | AUS

Facility Status City State Zip Country Details
University of Alabama at Birmingham Birmingham Alabama 35249 United States Details
Mayo Clinic Hospital - Arizona Scottsdale Arizona 85259 United States Details
City of Hope Duarte California 91010 United States Details
University of Colorado Denver Aurora Colorado 80045 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Memorial Sloan Kettering New York New York 10065 United States Details
Mount Sinai Hospital New York New York 10128 United States Details
University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
Tennessee Oncology - Nashville Nashville Tennessee 37203 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030-4009 United States Details
Peter MacCallum Cancer Center East Melbourne Victoria 3022 Australia Details
Alfred Hospital Melbourne Victoria 3004 Australia Details
University of Calgary Cumming School of Medicine Calgary Alberta T2N 5G2 Canada Details
Princess Margaret Cancer Center Toronto Ontario M5G 2M9 Canada Details
Jewish General Hospital Montreal Quebec H3T 1E2 Canada Details
Clinica Universidad de Navarra Pamplona/iruña Navarre 31008 Spain Details
Hospital Clinico Universitario de Salamanca Salamanca 37007 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field